Professional Documents
Culture Documents
05 Vrste Odbacivanja Organa
05 Vrste Odbacivanja Organa
05 Vrste Odbacivanja Organa
Transplantaciona imunologija
155
156
Transplantaciona imunologija
Autograft/Autologni graft:
Isograft/Sinergini ili
isogeni graft:
Alograft/Alogeni graft:
Ksenograft:
157
Transplantaciona imunologija
Transplantaciona imunologija
159
Transplantaciona imunologija
Transplantaciona imunologija
161
Transplantaciona imunologija
163
Transplantaciona imunologija
Transplantaciona imunologija
165
Transplantaciona imunologija
167
168
Transplantaciona imunologija
9. HRONINO ODBACIVANJE
Snani imunosupresivni agensi omoguavaju uspjeno tretiranje svih pa i
najteih akutnih epizoda odbacivanja sa visokim nivoom opstanka grafta u
prvih godinu dana, koji u veini centara iznosi oko 80-85%(55). Stabilan
gubitak dogaa se sa vremenom, to je atribut hroninog odbacivanja, tako
da 10-to godinji nivo opstanka za bubreni graft iznosi oko 60%.
Tanu definiciju hroninog odbacivanja je teko postaviti radi injenice
da razliiti procesi mogu dovesti do kasnog odbacivanja, od kojih nisu svi
direktno povezani sa imunim odgovorom grafta. Neki od njih su:
toksikacija lijekovima, povrat bolesti, infekcije i vaskularne komplikacije.
Histoloki, vaskularne promjene sa fibrointimalnim zadebljanjima
predominiraju, organ specifine parenhimalne promjene mogu takoe biti
u opticaju
Transplantaciona imunologija
169
Transplantaciona imunologija
171
172
Transplantaciona imunologija
Transplantaciona imunologija
173
13. LITERATURA
1. Farrar MA, Schreiber RD. The molecular cell biology of interferon-y and its
receptor. Annu Rev lmmunol, 1993; 11: 571-611.
2. Shoskes D, Parfrey NA, Halloran PF. Increased major histocompatibility
complex antige expression in unilateral ischemic acute tubular necrosis in the
mouse. Transplantation, 990; 49: 201-207.
3. Geenen V, Kroemer G. Multiple ways to cellular immune tolerance.
4. Chien YH, Davis MM. How alpha Tcell receptors "see" peptide/MHC
complexes. lmmunol Today, 1993; 14: 597-602.
5. Kotanides H, Reich NC Requirement of ryrosine phosphorylation for rapid
activation of aDNA binding factor by IL-4. Science, 1993; 262: 1265-1267.
6. Levin D, Constant S, Pasqualini T, Flavell R, Bottomly K. Role of dendritic
cells in the priming or CD4+ T Iymphocytes to peptide antigen in vivo.
lmmunol, 1993; 151: 6742 6750.
7. Watling D, Guschin D, Muller M, et al. Complementation by the protein
tyrosine kinas JAK2 of a mutant cellline defective in the interferon-y signal
transduction pathway. Nature, 1993; 366: 166-170.
8. Silvennoinen O, Ihle JN, Schlessinger J, Levy DE. Interferon-induced
nuclear signallin by Jak protein ryrosine kinases. Nature, 1993; 366: 583585.
9. Shu ai K, Ziemiecki A, Wilks AF, et al. Polypeptide signalling to the
nucleus through tyrosine phosphorylation ofJak and Stat proteins. Nature,
1993; 366: 580-583.
10. Sher A, Gazzinelli RT, Oswald Ip, et al. Role ofT cell derived cytokines in
the downregulation of immune responses in parasitic and retroviral infecrion.
lmmunol Rev, 199: 127: 183-204.
11. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte
emigration: the multistep paradigm. Cell, 1994; 76: 301-314.
12. Cockfield SM, Ramassar V, Noujaim J, van der Meide PH, Halloran PF.
Regulation of IFN-yexpression in vivo. IFN-y up-regulates expression of its
mRNA in normal and lipopolysaccharide-stimulated mice. lmmunol, 1993;
150: 717-725.
13. lmmunol Today, 1993; 14: 573-575.
14. Waer M, Strober S. The goal of specific immunologic unresponsiveness in
clinical kidny transplantation. Semin Nephrol, 1992; 12: 325-331.
15. Starz TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific
nonreactivity to 29 years after kidney allotransplantation. Transplantation,
174
Transplantaciona imunologija
175
176
Transplantaciona imunologija
Transplantaciona imunologija
177
178
Transplantaciona imunologija